ITI Pharma and Healthcare Fund vs Motilal Oswal Nifty MidSmall Healthcare Index Fund
Direct Plan, Growth option · Data as on 30-10-2026
ITI Pharma and Healthcare Fund is a Thematic fund and Motilal Oswal Nifty MidSmall Healthcare Index Fund is a mutual fund. In the year to 30-10-2026, ITI Pharma and Healthcare Fund (Direct) returned 9.4% and Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) returned 16.5%. ITI Pharma and Healthcare Fund charges 0.89% a year and Motilal Oswal Nifty MidSmall Healthcare Index Fund 0.80% (Direct plans). Their portfolios overlap 41.0%: they hold 21 of the same securities.
ITI Pharma and Healthcare Fund
Thematic
- 1 year return
- 9.4%
- Expense ratio
- 0.89%
- NAV
- ₹19.46
Motilal Oswal Nifty MidSmall Healthcare Index Fund
- 1 year return
- 16.5%
- Expense ratio
- 0.80%
- NAV
- ₹12.53
Which is better, ITI Pharma and Healthcare or Motilal Oswal Nifty MidSmall Healthcare Index? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Motilal Oswal Nifty MidSmall Healthcare Index returned more over 1 year: 16.5% against 9.4%.
- Motilal Oswal Nifty MidSmall Healthcare Index costs less: 0.80% a year against 0.89% (Direct plans).
- ITI Pharma and Healthcare fell less in its worst fall since 25-11-2024: −17.1% against −17.5%.
- ITI Pharma and Healthcare holds more in large companies: 35.9% of the fund in large caps against 0.0%.
- ITI Pharma and Healthcare is the larger fund: ₹266 Cr against ₹53 Cr.
- Their portfolios overlap 41.0%: 21 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | ITI Pharma and Healthcare Fund | Motilal Oswal Nifty MidSmall Healthcare Index Fund |
|---|---|---|
| Fund house | ITI Mutual Fund | Motilal Oswal Mutual Fund |
| Category | Thematic | Not available |
| AUM | ₹266 Cr (30-09-2026) | ₹53 Cr (30-09-2026) |
| NAV | ₹19.46 (Direct) | ₹12.53 (Direct) |
| Expense ratio (Direct) | 0.89% | 0.80% |
| Expense ratio (Regular) | 2.59% | 1.22% |
| Riskometer | Very High | Not available |
| Benchmark | NIFTY Healthcare TRI | Not available |
| Launch date | 08-11-2021 | Not available |
| Minimum investment | ₹5,000 | Not available |
| Lock in | None | Not available |
| Fund managers | Animesh Singh, Nilay Dalal | Not available |
| Exit load | Exit load of 0.50%, if redeemed within 3 months. | Not available |
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund (Direct) | 0.00% | −1.04% | +11.74% | +9.43% | +20.30% | -- | -- |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) | +1.79% | +0.06% | +15.24% | +16.51% | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Year-wise Returns
| Year | ITI Pharma and HealthcareITI Pharma and Healthcare | Motilal Oswal Nifty MidSmall Healthcare IndexMotilal Oswal Nifty MidSmall Healthcare Index |
|---|---|---|
| 2026to date | +14.07% | +17.99% |
| 2025 | −8.24% | −1.00% |
| 2024 | +43.95% | -- |
| 2023 | +34.39% | -- |
| 2022 | −6.68% | -- |
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Rolling Returns
Every holding period of both funds, against Nifty Healthcare Index TRI, the benchmark of ITI Pharma and Healthcare Fund
Rolling returns
Every 1-year holding period, 229 of them, one for each trading day from 25-11-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
ITI Pharma and Healthcare Fund (Direct)
Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)
Nifty Healthcare Index TRI
to
Dec 2025Feb 2025
to
Feb 2026Apr 2025
to
Apr 2026Jun 2025
to
Jun 2026Aug 2025
to
Aug 2026Oct 2025
to
Oct 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare | 30.6 | 17.9 | 31.0 | 15.3 | 5.2 | 0.0 | 0.0 | 3.9% | 5.2% | −9.3% | 17.4% | 0% |
| Motilal Oswal Nifty MidSmall Healthcare Index | 8.3 | 16.2 | 14.4 | 28.8 | 31.4 | 0.9 | 0.0 | 10.7% | 12.6% | −2.1% | 20.9% | 74% |
| Nifty Healthcare Index TRI | 3.9 | 23.1 | 22.7 | 38.4 | 11.8 | 0.0 | 0.0 | 9.1% | 10.0% | −2.0% | 18.6% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is Nifty Healthcare Index TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 25-11-2024. Past returns do not promise future returns.
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 04-11-2024 to 30-10-2026: 24 instalments, ₹2,40,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| ITI Pharma and HealthcareITI Pharma and Healthcare Fund (Direct) | ₹2,40,000 | ₹2,65,818 | ₹25,818 | 10.2% |
| Motilal Oswal Nifty MidSmall Healthcare IndexMotilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) | ₹2,40,000 | ₹2,82,623 | ₹42,623 | 16.7% |
ITI Pharma and HealthcareITI Pharma and Healthcare Fund (Direct)
Motilal Oswal Nifty MidSmall Healthcare IndexMotilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | ITI Pharma and Healthcare Fund (Direct) | Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +9.43% | +16.51% |
| Standard deviation | 13.63% | 15.34% |
| Sharpe ratio | 0.31 | 0.73 |
| Sortino ratio | 0.44 | 1.09 |
| Maximum drawdown | −11.7% (29-01-2026) | −10.4% (23-10-2026) |
| Beta | 0.91 | 1.00 |
| Alpha | −1.48% | −0.85% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | ITI Pharma and Healthcare Fund (Direct) | Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +14.34% | +11.42% |
| Standard deviation | 13.44% | 16.20% |
| Sharpe ratio | 0.63 | 0.36 |
| Sortino ratio | 0.89 | 0.49 |
| Maximum drawdown | −17.7% (17-06-2022) | −17.5% (28-02-2025) |
| Beta | 0.84 | 1.00 |
| Alpha | +1.08% | −0.77% |
From daily NAVs, 11-11-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
ITI Pharma and Healthcare Fund (Direct)
Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)
Nifty Healthcare Index TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund (Direct) | −17.1% | 02-01-2025 | 03-03-2025 | 24-06-2026 | 16 months | −4.2% |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) | −17.5% | 07-01-2025 | 28-02-2025 | 15-07-2025 | 5 months | −2.4% |
| Nifty Healthcare Index TRI | −15.7% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −2.9% |
From daily values since 25-11-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
ITI Pharma and Healthcare Fund (Direct)
Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)
Nifty Healthcare Index TRI
Against Nifty Healthcare Index TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| ITI Pharma and Healthcare Fund (Direct) | 85% | 103% | 5.17% |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct) | 100% | 89% | 5.63% |
From month-end values since 25-11-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Portfolio Overlap
From each fund's latest monthly portfolio: ITI Pharma and Healthcare Fund, September 2026; Motilal Oswal Nifty MidSmall Healthcare Index Fund, September 2026
Holdings in common
- Overlap
- 41.0%
- Held by both
- 21
- Only in ITI Pharma and Healthcare
- 16
- Only in Motilal Oswal Nifty MidSmall Healthcare Index
- 9
| Security | % of ITI Pharma and Healthcare | % of Motilal Oswal Nifty MidSmall Healthcare Index |
|---|---|---|
| Laurus Labs Limited | 4.02% | 11.83% |
| Aurobindo Pharma Limited | 4.01% | 7.09% |
| Mankind Pharma Limited | 3.78% | 4.35% |
| Alkem Laboratories Limited | 3.09% | 4.78% |
| Neuland Laboratories Limited | 3.07% | 2.82% |
| Fortis Healthcare Limited | 2.77% | 6.15% |
| Abbott India Limited | 2.14% | 2.17% |
| Lupin Limited | 2.04% | 7.57% |
| IPCA Laboratories Limited | 1.94% | 4.11% |
| Sai Life Sciences Limited | 1.87% | 3.23% |
| Global Health Limited | 2.85% | 1.86% |
| Aster DM Quality Care Limited | 1.59% | 2.86% |
| Piramal Pharma Limited | 1.27% | 1.97% |
| Anthem Biosciences Limited | 1.25% | 1.42% |
| Glenmark Pharmaceuticals Limited | 1.13% | 5.39% |
| Cohance Lifesciences Limited | 3.14% | 1.11% |
| Gland Pharma Limited | 1.03% | 3.54% |
| Poly Medicure Limited | 1.48% | 0.98% |
| GlaxoSmithKline Pharmaceuticals Limited | 0.96% | 1.76% |
| Biocon Limited | 0.81% | 3.96% |
| Syngene International Limited | 0.57% | 1.06% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 41.0% means 41.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in ITI Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited | 11.96% |
| Divi's Laboratories Limited | 9.51% |
| Apollo Hospitals Enterprise Limited | 5.45% |
| Torrent Pharmaceuticals Limited | 4.78% |
| Dr. Reddy's Laboratories Limited | 4.78% |
Largest holdings only in Motilal Oswal Nifty MidSmall Healthcare Index Fund
| Security | % of fund |
|---|---|
| Krishna Institute Of Medical Sciences Limited | 3.06% |
| Wockhardt Limited | 2.68% |
| Acutaas Chemicals Limited | 2.61% |
| Ajanta Pharma Limited | 2.53% |
| Dr. Lal Path Labs Limited | 2.38% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | ITI Pharma and Healthcare | Motilal Oswal Nifty MidSmall Healthcare Index |
|---|---|---|
| Equity | 99.3% | 100.1% |
| Debt | 0.0% | 0.0% |
| Cash and others | 0.7% | -0.1% |
Market cap of stocks
| Market cap | ITI Pharma and Healthcare | Motilal Oswal Nifty MidSmall Healthcare Index |
|---|---|---|
| Large Cap | 35.9% | 0.0% |
| Mid Cap | 40.5% | 67.9% |
| Small Cap | 23.0% | 32.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | ITI Pharma and Healthcare | Motilal Oswal Nifty MidSmall Healthcare Index |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.8% | 79.8% |
| Healthcare Services | 20.9% | 19.3% |
| Healthcare Equipment & Supplies | 1.5% | 1.0% |
| Consumer Durables | 1.2% | 0.0% |
| Chemicals & Petrochemicals | 0.9% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
ITI Pharma and Healthcare vs Motilal Oswal Nifty MidSmall Healthcare Index: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | ITI Pharma and Healthcare Fund | Motilal Oswal Nifty MidSmall Healthcare Index Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.89% | 0.80% |
| Base expense ratio (Direct) | 0.58% | 0.54% |
| Total expense ratio (Regular) | 2.59% | 1.22% |
| Base expense ratio (Regular) | 2.10% | 0.90% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare ITI Pharma and Healthcare with
ITI Pharma and Healthcare Fund vs Motilal Oswal Nifty MidSmall Healthcare Index Fund: Frequently Asked Questions
What is the difference between ITI Pharma and Healthcare Fund and Motilal Oswal Nifty MidSmall Healthcare Index Fund?
ITI Pharma and Healthcare Fund is a Thematic fund, Motilal Oswal Nifty MidSmall Healthcare Index Fund is a mutual fund, run by ITI Mutual Fund and Motilal Oswal Mutual Fund. Their portfolios overlap 41.0%. ITI Pharma and Healthcare Fund charges 0.89% a year and Motilal Oswal Nifty MidSmall Healthcare Index Fund 0.80%.
Which has given higher returns, ITI Pharma and Healthcare Fund or Motilal Oswal Nifty MidSmall Healthcare Index Fund?
Over 1 year: ITI Pharma and Healthcare Fund +9.43%, Motilal Oswal Nifty MidSmall Healthcare Index Fund +16.51%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, ITI Pharma and Healthcare Fund or Motilal Oswal Nifty MidSmall Healthcare Index Fund?
Motilal Oswal Nifty MidSmall Healthcare Index Fund charges less: 0.80% a year against 0.89%. These are the Direct plans' total expense ratios reported to AMFI.
How much do ITI Pharma and Healthcare Fund and Motilal Oswal Nifty MidSmall Healthcare Index Fund overlap?
41.0%. They hold 21 of the same securities, the largest shared ones being LAURUSLABS, AUROPHARMA, MANKIND. From each fund's latest monthly portfolio.
Can I invest in both ITI Pharma and Healthcare Fund and Motilal Oswal Nifty MidSmall Healthcare Index Fund?
Yes. 41.0% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.